>>Signaling Pathways>> GPCR/G protein>> Prostaglandin Receptor>>Etersalate (Eterylate)

Etersalate (Eterylate)

Catalog No.GC32540

Etersalate(Eterylate)는 혈소판 기능을 억제하고 트롬복산 A2(TXA2) 수치를 감소시킵니다.

Products are for research use only. Not for human use. We do not sell to patients.

Etersalate (Eterylate) Chemical Structure

Cas No.: 62992-61-4

Size 가격 재고 수량
1mg
US$184.00
재고 있음
5mg
US$368.00
재고 있음
10mg
US$625.00
재고 있음
20mg
US$1,103.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Etersalate inhibits platelet function and decreases thromboxane A2 (TXA2) levels.

Ex vivo antiplatelet properties of Etersalate and its effects on serum thromboxane A2 (TXA2) levels and prostaglandin I2 (PGI2) generation are studied in human volunteers at two levels of oral dosing. Etersalate inhibits at the lower dosage platelet function and decreased TXA2 levels, but PGI2 generation from rat aortic rings is stimulated when incubated with plasma from Etersalate-treated donors. Blood coagulation parameters remain within normal values. Etersalate administration can act on platelet arachidonate metabolism at a different level than that of the cyclooxygenase pathway[1].

[1]. Ortega MP, et al. Effect of etersalate on human platelet responsiveness. A study in healthy volunteers. Arzneimittelforschung. 1987 Feb;37(2):214-7.

리뷰

Review for Etersalate (Eterylate)

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Etersalate (Eterylate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.